AtriCure, Inc. (ATRC) was a big mover last session, as its shares rose nearly 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the uptrend for the company since Jul 17, as the stock is now up almost 11%.
In the last 30 days, the company did not witness any estimate revision and the Zacks Consensus Estimate also remained unchanged. Yesterday’s price rally is encouraging though, so make sure to keep an eye on this stock going forward.
AtriCure currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Other better-ranked stocks in the med-products industry include Alere Inc. (ALR), Boston Scientific Corporation (BSX) and Cardiovascular Systems Inc. (CSII). All three carry a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
CARDIOVASCULAR SYSTEMS INC (CSII): Free Stock Analysis Report
ALERE INC (ALR): Free Stock Analysis Report
BOSTON SCIENTIFIC CORP (BSX): Free Stock Analysis Report
ATRICURE INC (ATRC): Free Stock Analysis Report
Zacks Investment Research
- Personal Investing Ideas & Strategies
- Finance Trading